Positioning no disclosures inside 60 days, left as found
Options put/call open interest 1.11, read 2026-11-03
Ethical does not pass the values gate
Price261.35 USD
Fair value405.00
Ethical score70.0/100
Value readUndervaluedas of 6 Nov 2026
Our investment reviews on this name
2026-11-04Read Markup265.01-1.4% to today Distribution gives way to Markup first Markup read since July
2026-08-31Read Distribution262.63-0.5% to today ✓Markup gives way to Distribution after a 19% slide in 4 weeks
2026-07-31Read Markup326.06-19.8% to today Distribution gives way to Markup
2026-07-02Read Distribution325.33-19.7% to today ✓First review on file: Distribution
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Group 1 Automotive, Inc. holds its Markup at $261.35. Consolidating, no directional conviction, held for 8 days.
As held on the ledger · 2026-11-06
Phase
Markup
Quantitative state
Consolidating, no directional conviction, held for 8 days
Price at the screen
$261.35
Valuation
8.66 trailing · 7.04 forward price to earnings
Values screen
FAIL· score 70.0
Beta
0.97
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
56.72%
Below 33%
Interest-bearing debt is 56.7% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
3.29%
Below 49%
Money owed to the company is 3.3% of assets, under the 49% limit.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Group 1 Automotive,'s business is in a permissible area, but its interest-bearing debt is about 57% of the company, well over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-11-07. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when GPI's ethical verdict changes
Today GPI does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 6 Nov 2026: it trades at roughly a 34% discount to our $405.00 fair value.
Fair value range in USD, drawn from the 2026-11-06 screen. The gold marker is the market price at the same screen. A 35.5% discount to the base estimate.
Where our models see it going: fair-value estimate $405.00, with a range of $405.00 to $533.00, dated to the 2026-11-06 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Dealerships Trade Cheap But Signal Cyclical Trap
Picture a forecourt where every used car has a low sticker price yet the engine hours tell a different story. Group 1 Automotive sits in exactly that spot, running showrooms across the US and UK with new and used sales plus service and insurance contracts. Revenue is already shrinking two percent and net margins sit at just one percent, so the business feels the first chill of any slowdown in consumer spending on big-ticket items.
The forward multiple of seven times earnings looks attractive next to an analyst median target of four hundred eighteen dollars and our own higher fair-value estimate. Yet the opportunity rating stays at none because auto retail is a classic cyclical sector where low multiples often mark peak rather than trough earnings. ROE of eleven percent and an unknown moat give little comfort when volumes can swing sharply with interest rates and household budgets.
The ethical screen clears without issue, but that alone does not turn a thin-margin, negative-growth franchise into a durable compounder. Investors chasing the headline multiple risk catching the top of the cycle instead of a genuine bargain. Analysis, not advice.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
GPI trades on the NYSE. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markup · changed$265.01+9.0%Entry 16
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 9.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (12 analysts) rates it buy, with a mean price target of $434. Insiders have been net buyers over the past quarter.
2026-10-28Distribution$243.02+0.0%Entry 15
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (12 analysts) rates it buy, with a mean price target of $434. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-27Distribution$243.02+0.0%Entry 14
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (12 analysts) rates it buy, with a mean price target of $434. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-26Distribution$243.02+0.0%Entry 13
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (12 analysts) rates it buy, with a mean price target of $434. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-25Distribution$243.02+0.0%Entry 12
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (12 analysts) rates it buy, with a mean price target of $434. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-24Distribution$243.02+0.0%Entry 11
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (12 analysts) rates it buy, with a mean price target of $434. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-23Distribution$243.02+0.0%Entry 10
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (12 analysts) rates it buy, with a mean price target of $434. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-22Distribution$243.02+0.0%Entry 9
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (12 analysts) rates it buy, with a mean price target of $434. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-21Distribution$243.02+4.9%Entry 8
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 4.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (12 analysts) rates it buy, with a mean price target of $434. Insiders have been net buyers over the past quarter. It reported earnings in this window, a natural checkpoint for the thesis.
2026-10-18Distribution$231.59-6.0%Entry 7
The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 6.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows negative risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 26%. Our forward projection puts the odds of a 10% gain over the next month near 21%. The street (12 analysts) rates it buy, with a mean price target of $434. Insiders have been net buyers over the past quarter.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
